VIVUS, Inc. (VVUS) Analysts See $-0.11 EPS

Retrieved on: 2018-07-28 06:04:49

Tags for this article:

NASDAQ

Health care

Vivus

Phentermine/topiramate

Drugs

Anorectics

S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

VIVUS, Inc. (VVUS) Analysts See $-0.11 EPS. View article details on hiswai:

Excerpt

<div><b>Vanguard Group</b> Inc Inc Inc holds 0% in VIVUS, Inc. (NASDAQ:VVUS) or 3.44M shares. Bancorporation Of America De invested 0% of its portfolio in ...</div>

Article found on:

View Original Article